A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes-Reference-Cited by-同舟云学术

A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes

Published:2023-03 Issue:3 Volume:78 Page:471-478
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ajmera Veeral^ORCID,Cepin Sandra,Tesfai Kaleb^ORCID,Hofflich Heather,Cadman Karen,Lopez Scarlett,Madamba Egbert,Bettencourt Ricki,Richards Lisa,Behling Cynthia,Sirlin Claude B.^ORCID,Loomba Rohit^ORCID

Funder

National Heart, Lung, and Blood Institute

National Institute of Diabetes and Digestive and Kidney Diseases

Gilead Sciences

National Center for Advancing Translational Sciences

National Institute on Alcohol Abuse and Alcoholism

Publisher

Elsevier BV

Subject

Hepatology

Reference37 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology (Baltimore, Md),2016

2. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of medicare data;Loomba;Aliment Pharmacol Ther,2020

3. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer;Huang;Cel Metab,2022

4. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management;McPherson;J Hepatol,2015

5. Association of histologic disease activity with progression of nonalcoholic fatty liver disease;Kleiner;JAMA Netw Open,2019

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Visceral Fat and Diabetes: Associations With Liver Fibrosis in Metabolic Dysfunction–Associated Steatotic Liver Disease;Journal of Clinical and Experimental Hepatology;2025-01

2. Cordycepin alleviates diabetes mellitus-associated hepatic fibrosis by inhibiting SOX9-mediated Wnt/β-catenin signal axis;Bioorganic Chemistry;2024-12

3. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

4. Kurarinol restrains non-alcoholic fatty liver disease-associated hepatocellular carcinoma (HCC) progression by suppressing EGFR signaling;Journal of Functional Foods;2024-10

5. Patients with chronic liver diseases are at risk for diabetes even before development of cirrhosis;Clinics and Research in Hepatology and Gastroenterology;2024-10